Corcept Therapeutics released FY2025 Semi-Annual Earnings on July 31 After-Market EST, actual revenue USD 351.64 M, actual EPS USD 0.4603

Brief Summary

Corcept Therapeutics reported its 2025 first-half financial results on July 31, 2025 (US Eastern Time), achieving a revenue of $351.64 million, a net profit of $54.90 million, and an earnings per share (EPS) of $0.4603.

Impact of The News

Event Overview and Market Context